Brief: Medacta Group Reports H1 2023 Revenue Of Eur 255.1 Mln
Sept 22 (Reuters) - Medacta Group Sa MOVE.S :
* REPORTS STRONG REVENUE GROWTH AT 21.4% AT CONSTANT
CURRENCY AND
ADJUSTED EBITDA MARGIN AT 28.2% IN THE FIRST SEMESTER 2023
* 1H 2023 REVENUE INCREASED TO EURO 255.1 MILLION, OR 21.4%
C.C.^1
(20.8% REPORTED) FROM 1H 2022
* SEES FY ADJUSTED EBITDA IN C.C. IS PREDICTED TO REMAIN
LARGELY
IN LINE WITH 2022
Source text for Eikon: ID:nEQbkC4Kka
Further company coverage: MOVE.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medacta SA
See all newsBrief: Medacta Group Updates 2026 Guidance, Reiterates 2024-2027 Mid-Term Outlook
Swiss medical device maker Medacta H1 revenue rises on Asia Pacific, EMEA strength
Brief: Medacta H1 Adjusted EBITDA EUR 97 Million
Switzerland's Medacta H1 revenue rises 9.7% in constant currency
Brief: Medacta H1 Revenue EUR 368 Million